Publications

All our publications

*Listed are the articles found in the PubMed database.

Publications by “Gema Moreno Bueno”

Transcriptional repression of SOX2 by p53 in cancer cells regulates cell identity and migration.

Lado-Fernández, P, Vilas, JM, Fernandes, T, Carneiro, C, Da Silva-Álvarez, S, Estévez-Souto, V, Pedrosa, P, González-Barcia, M, Abatti, LE, Mitchell, JA, Rivas, C, Moreno-Bueno, G , Vidal, A, Collado, M.

Radiotherapy resistance driven by Asparagine endopeptidase through ATR pathway modulation in breast cancer.

Morillo-Huesca, M, G López-Cepero, I, Conesa-Bakkali, R, Tomé, M, Watts, C, Huertas, P, Moreno-Bueno, G , Durán, RV, Martínez-Fábregas, J.

Microglial reprogramming enhances antitumor immunity and immunotherapy response in melanoma brain metastases.

Rodriguez-Baena, FJ, Marquez-Galera, A, Ballesteros-Martinez, P, Castillo, A, Diaz, E, Moreno-Bueno, G , Lopez-Atalaya, JP, Sanchez-Laorden, B.

Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations.

Youssef, KK, Narwade, N, Arcas, A, Marquez-Galera, A, Jiménez-Castaño, R, Lopez-Blau, C, Fazilaty, H, García-Gutierrez, D, Cano, A , Galcerán, J, Moreno-Bueno, G , Lopez-Atalaya, JP, Nieto, MA.

Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application.

Casas-Arozamena, C, Vilar, A, Cueva, J, Arias, E, Sampayo, V, Diaz, E, Oltra, SS , Moiola, CP, Cabrera, S, Cortegoso, A, Curiel, T, Abalo, A, Pamies Serrano, M, Domingo, S, Padilla-Iserte, P, Arnaez de la Cruz, M, Hernández, A, García-Pineda, V, Ruiz-Bañobre, J, López, R, Matias-Guiu, X, Colás, E, Gil-Moreno, A, Abal, M, Moreno-Bueno, G , Muinelo-Romay, L.

Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors.

Moreno-Moreno, E, Caniego-Casas, T, Carretero-Barrio, I, Cortés, A, Muriel, A, Domínguez-Rullán, JA, Martín-Gromaz, C, Moreno-Bueno, G , Matías-Guiu, X, Palacios, J, Pérez-Mies, B.

Tumor-Intrinsic Perinuclear LOXL2: Prognostic Relevance and Relationship with YAP1 Activation Status in Oral Squamous Cell Carcinoma.

Rodrigo, JP, Moreno-Bueno, G , Lequerica-Fernández, P, Rodríguez-Santamarta, T, Díaz, E, Prieto-Fernández, L, Álvarez-Teijeiro, S, García-Pedrero, JM, de Vicente, JC.

Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management.

Rosas-Alonso, R, Colmenarejo-Fernández, J, Pernía, O, Burdiel, M, Rodríguez-Antolín, C, Losantos-García, I, Rubio, T, Moreno-Velasco, R, Esteban-Rodríguez, I, Martínez-Marín, V, Yubero, P, Costa-Fraga, N, Díaz-Lagares, A, López-López, R, Díaz-Martin, E, García, JF, Sánchez, CV, Gandía-González, ML, Moreno-Bueno, G , de Castro, J, de Cáceres, II.

Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.

Tundidor, I, Seijo-Vila, M, Blasco-Benito, S, Rubert-Hernández, M, Adámez, S, Andradas, C, Manzano, S, Álvarez-López, I, Sarasqueta, C, Villa-Morales, M, González-Lois, C, Ramírez-Medina, E, Almoguera, B, Sánchez-López, AJ, Bindila, L, Hamann, S, Arnold, N, Röcken, C, Heras-Murillo, I, Sancho, D, Moreno-Bueno, G , Caffarel, MM, Guzmán, M, Sánchez, C, Pérez-Gómez, E .

Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells.

Oltra, SS , Colomo, S , Sin, L , Pérez-López, M , Lázaro, S , Molina-Crespo, A , Choi, KH, Ros-Pardo, D, Martínez, L , Morales, S , González-Paramos, C , Orantes, A, Soriano, M, Hernández, A, Lluch, A, Rojo, F, Albanell, J, Gómez-Puertas, P, Ko, JK, Sarrió, D , Moreno-Bueno, G .

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.

Garcia-Casado, Z, Oaknin, A, Mendiola, M , Alkorta-Aranburu, G, Antunez-Lopez, JR, Moreno-Bueno, G , Palacios, J, Yubero, A, Marquez, R, Gallego, A, Sanchez-Heras, AB, Lopez-Guerrero, JA, Perez-Segura, C, Barretina-Ginesta, P, Alarcon, J, Gaba, L, Marquez, A, Matito, J, Cueva, J, Palacio, I, Iglesias, M, Arcusa, A, Sanchez-Lorenzo, L, Guerra-Alia, E, Romero, I, Vivancos, A.

Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation.

Gámez-Chiachio, M , Molina-Crespo, Á , Ramos-Nebot, C , Martinez-Val, J, Martinez, L , Gassner, K, Llobet, FJ, Soriano, M, Hernandez, A, Cordani, M , Bernadó-Morales, C, Diaz, E, Rojo-Sebastian, A, Triviño, JC, Sanchez, L, Rodríguez-Barrueco, R, Arribas, J, Llobet-Navás, D, Sarrió, D , Moreno-Bueno, G .

Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma.

Alonso-Nocelo, M , Ruiz-Cañas, L , Sancho, P, Görgülü, K, Alcalá, S , Pedrero, C , Vallespinos, M , López-Gil, JC , Ochando, M , García-García, E, David Trabulo, SM, Martinelli, P, Sánchez-Tomero, P , Sánchez-Palomo, C, Gonzalez-Santamaría, P , Yuste, L , Wörmann, SM, Kabacaoğlu, D, Earl, J, Martin, A , Salvador, F , Valle, S , Martin-Hijano, L , Carrato, A, Erkan, M, García-Bermejo, L, Hermann, PC, Algül, H, Moreno-Bueno, G , Heeschen, C, Portillo, F , Cano, A , Sainz, B .

Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression.

Mota, A , Oltra, SS , Selenica, P, Moiola, CP, Casas-Arozamena, C, López-Gil, C, Diaz, E, Gatius, S, Ruiz-Miro, M, Calvo, A, Rojo-Sebastián, A, Hurtado, P, Piñeiro, R, Colas, E, Gil-Moreno, A, Reis-Filho, JS, Muinelo-Romay, L, Abal, M, Matias-Guiu, X, Weigelt, B, Moreno-Bueno, G .

Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer.

Abreu, M, Cabezas-Sainz, P, Alonso-Alconada, L, Ferreirós, A, Mondelo-Macía, P, Lago-Lestón, RM, Abalo, A, Díaz, E, Palacios-Zambrano, S , Rojo-Sebastian, A, López-López, R, Sánchez, L, Moreno-Bueno, G , Muinelo-Romay, L.

Corrigendum to "Prostaglandin F-induced prostate transmembrane protein, androgen induced 1 mediates ovarian cancer progression increasing epithelial plasticity" [Neoplasia 21 (2019) 1073-1084].

Jiménez-Segovia, A, Mota, A , Rojo-Sebastián, A, Barrocal, B, Rynne-Vidal, A, García-Bermejo, ML, Gómez-Bris, R, Hawinkels, LJAC, Sandoval, P, Garcia-Escudero, R, López-Cabrera, M, Moreno-Bueno, G , Fresno, M, Stamatakis, K.

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer.

Casas-Arozamena, C, Díaz, E, Moiola, CP, Alonso-Alconada, L, Ferreirós, A, Abalo, A, Gil, CL, Oltra, SS , de Santiago, J, Cabrera, S, Sampayo, V, Bouso, M, Arias, E, Cueva, J, Colas, E, Vilar, A, Gil-Moreno, A, Abal, M, Moreno-Bueno, G , Muinelo-Romay, L.

Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells.

Abreu, M, Cabezas-Sainz, P, Pereira-Veiga, T, Falo, C, Abalo, A, Morilla, I, Curiel, T, Cueva, J, Rodríguez, C, Varela-Pose, V, Lago-Lestón, R, Mondelo, P, Palacios, P, Moreno-Bueno, G , Cano, A , García-Caballero, T, Pujana, MÁ, Sánchez-Piñón, L, Costa, C, López, R, Muinelo-Romay, L.

Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer.

Herrero, C, de la Fuente, A, Casas-Arozamena, C, Sebastian, V, Prieto, M, Arruebo, M, Abalo, A, Colás, E, Moreno-Bueno, G , Gil-Moreno, A, Vilar, A, Cueva, J, Abal, M, Muinelo-Romay, L.

Prostaglandin F-induced Prostate Transmembrane Protein, Androgen Induced 1 mediates ovarian cancer progression increasing epithelial plasticity.

Jiménez-Segovia, A, Mota, A , Rojo-Sebastián, A, Barrocal, B, Rynne-Vidal, A, García-Bermejo, ML, Gómez-Bris, R, Hawinkels, LJAC, Sandoval, P, Garcia-Escudero, R, López-Cabrera, M, Moreno-Bueno, G , Fresno, M, Stamatakis, K.

MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.

Majem, B, Parrilla, A, Jiménez, C, Suárez-Cabrera, L, Barber, M, Marín, A, Castellví, J, Tamayo, G, Moreno-Bueno, G , Ponce, J, Matias-Guiu, X, Alameda, F, Romero, I, Sánchez, JL, Pérez-Benavente, A, Moran, S, Esteller, M, Reventós, J, Rigau, M, Gil-Moreno, A, Segura, MF, Santamaría, A.

Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.

Blasco-Benito, S, Moreno, E, Seijo-Vila, M, Tundidor, I, Andradas, C, Caffarel, MM, Caro-Villalobos, M, Urigüen, L, Diez-Alarcia, R, Moreno-Bueno, G , Hernández, L, Manso, L, Homar-Ruano, P, McCormick, PJ, Bibic, L, Bernadó-Morales, C, Arribas, J, Canals, M, Casadó, V, Canela, EI, Guzmán, M, Pérez-Gómez, E , Sánchez, C.

The Ras-related gene ERAS is involved in human and murine breast cancer.

Suárez-Cabrera, C, de la Peña, B, González, LL, Page, A, Martínez-Fernández, M, Casanova, ML, Paramio, JM, Rojo-Sebastián, A, Moreno-Bueno, G , Maroto, A, Ramírez, Á, Navarro, M.

In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines.

Rincón-Fernández, D, Culler, MD, Tsomaia, N, Moreno-Bueno, G , Luque, RM, Gahete, MD, Castaño, JP.

A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination.

Figueras, A, Alsina-Sanchís, E, Lahiguera, Á, Abreu, M, Muinelo-Romay, L, Moreno-Bueno, G , Casanovas, O, Graupera, M, Matias-Guiu, X, Vidal, A, Villanueva, A, Viñals, F.

Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells.

Rodríguez-Ubreva, J, Català-Moll, F, Obermajer, N, Álvarez-Errico, D, Ramirez, RN, Company, C, Vento-Tormo, R, Moreno-Bueno, G , Edwards, RP, Mortazavi, A, Kalinski, P, Ballestar, E.

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

Mateo, F, Arenas, EJ, Aguilar, H, Serra-Musach, J, de Garibay, GR, Boni, J, Maicas, M, Du, S, Iorio, F, Herranz-Ors, C, Islam, A, Prado, X, Llorente, A, Petit, A, Vidal, A, Català, I, Soler, T, Venturas, G, Rojo-Sebastian, A, Serra, H, Cuadras, D, Blanco, I, Lozano, J, Canals, F, Sieuwerts, AM, de Weerd, V, Look, MP, Puertas, S, García, N, Perkins, AS, Bonifaci, N, Skowron, M, Gómez-Baldó, L, Hernández, V, Martínez-Aranda, A, Martínez-Iniesta, M, Serrat, X, Cerón, J, Brunet, J, Barretina, MP, Gil, M, Falo, C, Fernández, A, Morilla, I, Pernas, S, Plà, MJ, Andreu, X, Seguí, MA, Ballester, R, Castellà, E, Nellist, M, Morales, S, Valls, J, Velasco, A, Matias-Guiu, X, Figueras, A, Sánchez-Mut, JV, Sánchez-Céspedes, M, Cordero, A, Gómez-Miragaya, J, Palomero, L, Gómez, A, Gajewski, TF, Cohen, EEW, Jesiotr, M, Bodnar, L, Quintela-Fandino, M, López-Bigas, N, Valdés-Mas, R, Puente, XS, Viñals, F, Casanovas, O, Graupera, M, Hernández-Losa, J, Ramón Y Cajal, S, García-Alonso, L, Saez-Rodriguez, J, Esteller, M, Sierra, A, Martín-Martín, N, Matheu, A, Carracedo, A, González-Suárez, E, Nanjundan, M, Cortés, J, Lázaro, C, Odero, MD, Martens, JWM, Moreno-Bueno, G , Barcellos-Hoff, MH, Villanueva, A, Gomis, RR, Pujana, MA.

Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.

García-Sanz, P , Triviño, JC, Mota, A , Pérez López, M, Colás, E, Rojo-Sebastián, A, García, Á, Gatius, S, Ruiz, M, Prat, J, López-López, R, Abal, M, Gil-Moreno, A, Reventós, J, Matias-Guiu, X, Moreno-Bueno, G .

Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.

Devis, L, Moiola, CP, Masia, N, Martinez-Garcia, E, Santacana, M, Stirbat, TV, Brochard-Wyart, F, García, Á, Alameda, F, Cabrera, S, Palacios, J, Moreno-Bueno, G , Abal, M, Thomas, W, Dufour, S, Matias-Guiu, X, Santamaria, A, Reventos, J, Gil-Moreno, A, Colas, E.

Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers.

Mota, A , Colás, E, García-Sanz, P , Campoy, I, Rojo-Sebastián, A, Gatius, S, García, Á, Chiva, L, Alonso, S, Gil-Moreno, A, González-Tallada, X, Díaz-Feijoo, B, Vidal, A, Ziober-Malinowska, P, Bobiński, M, López-López, R, Abal, M, Reventós, J, Matias-Guiu, X, Moreno-Bueno, G .

The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients.

Gahete, MD, Rincón-Fernández, D, Durán-Prado, M, Hergueta-Redondo, M , Ibáñez-Costa, A, Rojo-Sebastián, A, Gracia-Navarro, F, Culler, MD, Casanovas, O, Moreno-Bueno, G , Luque, RM, Castaño, JP.

Cancer network activity associated with therapeutic response and synergism.

Serra-Musach, J, Mateo, F, Capdevila-Busquets, E, de Garibay, GR, Zhang, X, Guha, R, Thomas, CJ, Grueso, J, Villanueva, A, Jaeger, S, Heyn, H, Vizoso, M, Pérez, H, Cordero, A, Gonzalez-Suarez, E, Esteller, M, Moreno-Bueno, G , Tjärnberg, A, Lázaro, C, Serra, V, Arribas, J, Benson, M, Gustafsson, M, Ferrer, M, Aloy, P, Pujana, MÀ.

Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.

Hellner, K, Miranda, F, Fotso Chedom, D, Herrero-Gonzalez, S, Hayden, DM, Tearle, R, Artibani, M, KaramiNejadRanjbar, M, Williams, R, Gaitskell, K, Elorbany, S, Xu, R, Laios, A, Buiga, P, Ahmed, K, Dhar, S, Zhang, RY, Campo, L, Myers, KA, Lozano, M, Ruiz-Miró, M, Gatius, S, Mota, A , Moreno-Bueno, G , Matias-Guiu, X, Benítez, J, Witty, L, McVean, G, Leedham, S, Tomlinson, I, Drmanac, R, Cazier, JB, Klein, R, Dunne, K, Bast, RC, Kennedy, SH, Hassan, B, Lise, S, Garcia, MJ, Peters, BA, Yau, C, Sauka-Spengler, T, Ahmed, AA.

Study of breast cancer incidence in patients of lymphangioleiomyomatosis.

Nuñez, O, Román, A, Johnson, SR, Inoue, Y, Hirose, M, Casanova, Á, de Garibay, GR, Herranz, C, Bueno-Moreno, G , Boni, J, Mateo, F, Petit, A, Climent, F, Soler, T, Vidal, A, Sánchez-Mut, JV, Esteller, M, López, JI, García, N, Gumà, A, Ortega, R, Plà, MJ, Campos, M, Ansótegui, E, Molina-Molina, M, Valenzuela, C, Ussetti, P, Laporta, R, Ancochea, J, Xaubet, A, Pollán, M, Pujana, MA.

Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.

Pérez-Gómez, E , Andradas, C, Blasco-Benito, S, Caffarel, MM, García-Taboada, E, Villa-Morales, M, Moreno, E, Hamann, S, Martín-Villar, E , Flores, JM, Wenners, A, Alkatout, I, Klapper, W, Röcken, C, Bronsert, P, Stickeler, E, Staebler, A, Bauer, M, Arnold, N, Soriano, J, Pérez-Martínez, M, Megías, D, Moreno-Bueno, G , Ortega-Gutiérrez, S, Artola, M, Vázquez-Villa, H, Quintanilla, M , Fernández-Piqueras, J, Canela, EI, McCormick, PJ, Guzmán, M, Sánchez, C.

A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry.

Santacana, M, Maiques, O, Valls, J, Gatius, S, Abó, AI, López-García, MÁ, Mota, A , Reventós, J, Moreno-Bueno, G , Palacios, J, Bartosch, C, Dolcet, X, Matias-Guiu, X.

MicroRNAs as prognostic markers in ovarian cancer.

Llauradó, M, Majem, B, Altadill, T, Lanau, L, Castellví, J, Sánchez-Iglesias, JL, Cabrera, S, De la Torre, J, Díaz-Feijoo, B, Pérez-Benavente, A, Colás, E, Olivan, M, Doll, A, Alameda, F, Matias-Guiu, X, Moreno-Bueno, G , Carey, MS, Del Campo, JM, Gil-Moreno, A, Reventós, J, Rigau, M.

MicroRNA-dependent regulation of transcription in non-small cell lung cancer.

Molina-Pinelo, S, Gutiérrez, G, Pastor, MD, Hergueta, M, Moreno-Bueno, G , García-Carbonero, R, Nogal, A, Suárez, R, Salinas, A, Pozo-Rodríguez, F, Lopez-Rios, F, Agulló-Ortuño, MT, Ferrer, I, Perpiñá, A, Palacios, J, Carnero, A, Paz-Ares, L.

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.

Romero-Pérez, L, Castilla, MÁ, López-García, MÁ, Díaz-Martín, J, Biscuola, M, Ramiro-Fuentes, S, Oliva, E, Matias-Guiu, X, Prat, J, Cano, A , Moreno-Bueno, G , Palacios, J.

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Peinado, H , Alečković, M, Lavotshkin, S, Matei, I, Costa-Silva, B, Moreno-Bueno, G , Hergueta-Redondo, M , Williams, C, García-Santos, G, Ghajar, C, Nitadori-Hoshino, A, Hoffman, C, Badal, K, Garcia, BA, Callahan, MK, Yuan, J, Martins, VR, Skog, J, Kaplan, RN, Brady, MS, Wolchok, JD, Chapman, PB, Kang, Y, Bromberg, J, Lyden, D.

The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells.

Durán-Prado, M, Gahete, MD, Hergueta-Redondo, M, Martínez-Fuentes, AJ, Córdoba-Chacón, J, Palacios, J, Gracia-Navarro, F, Moreno-Bueno, G , Malagón, MM, Luque, RM, Castaño, JP.

KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.

Llobet, D, Eritja, N, Domingo, M, Bergada, L, Mirantes, C, Santacana, M, Pallares, J, Macià, A, Yeramian, A, Encinas, M, Moreno-Bueno, G , Palacios, J, Lewis, RE, Matias-Guiu, X, Dolcet, X.

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.

Castilla, MÁ, Moreno-Bueno, G , Romero-Pérez, L, Van De Vijver, K, Biscuola, M, López-García, MÁ, Prat, J, Matías-Guiu, X, Cano, A , Oliva, E, Palacios, J.

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.

Castilla, MA, Moreno-Bueno, G , Romero-Pérez, L, De Vijver, KV, Biscuola, M, López-García, MA, Prat, J, Matías-Guiu, X, Cano, A , Oliva, E, Palacios, J.

Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma.

Fernandez-Marcos, PJ, Abu-Baker, S, Joshi, J, Galvez, A, Castilla, EA, Cañamero, M, Collado, M, Saez, C, Moreno-Bueno, G , Palacios, J, Leitges, M, Serrano, M, Moscat, J, Diaz-Meco, MT.

Tiling path genomic profiling of grade 3 invasive ductal breast cancers.

Natrajan, R, Lambros, MB, Rodríguez-Pinilla, SM, Moreno-Bueno, G , Tan, DS, Marchió, C, Vatcheva, R, Rayter, S, Mahler-Araujo, B, Fulford, LG, Hungermann, D, Mackay, A, Grigoriadis, A, Fenwick, K, Tamber, N, Hardisson, D, Tutt, A, Palacios, J, Lord, CJ, Buerger, H, Ashworth, A, Reis-Filho, JS.

Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer.

Durán, MC, Vega, F, Moreno-Bueno, G , Artiga, MJ, Sanchez, L, Palacios, J, Ridley, A, Timms, JF.

JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.

Caffarel, MM, Moreno-Bueno, G , Cerutti, C, Palacios, J, Guzman, M, Mechta-Grigoriou, F, Sanchez, C.

Inhibition of paclitaxel-induced proteasome activation influences paclitaxel cytotoxicity in breast cancer cells in a sequence-dependent manner.

Hernández-Vargas, H, von Kobbe, C, Sánchez-Estévez, C, Julián-Tendero, M , Palacios, J, Moreno-Bueno, G .

Telling cells how to die: docetaxel therapy in cancer cell lines.

Hernández-Vargas, H, Palacios, J, Moreno-Bueno, G .

Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.

Moreno-Bueno, G , Fernandez-Marcos, PJ, Collado, M, Tendero, MJ, Rodriguez-Pinilla, SM, Garcia-Cao, I, Hardisson, D, Diaz-Meco, MT, Moscat, J, Serrano, M, Palacios, J.

Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.

Molina-Arcas, M, Moreno-Bueno, G , Cano-Soldado, P, Hernández-Vargas, H, Casado, FJ, Palacios, J, Pastor-Anglada, M.

Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53.

Hernández-Vargas, H, Ballestar, E, Carmona-Saez, P, von Kobbe, C, Bañón-Rodríguez, I, Esteller, M, Moreno-Bueno, G , Palacios, J.

Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.

Matar, P, Rojo, F, Cassia, R, Moreno-Bueno, G , Di Cosimo, S, Tabernero, J, Guzmán, M, Rodriguez, S, Arribas, J, Palacios, J, Baselga, J.

Molecular alterations associated with cyclin D1 overexpression in endometrial cancer.

Moreno-Bueno, G , Rodríguez-Perales, S, Sánchez-Estévez, C, Marcos, R, Hardisson, D, Cigudosa, JC, Palacios, J.

Re: Scholten et al. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201: 460-465.

Moreno-Bueno, G , Hardisson, D, Prat, J, Matías-Guiu, J, Palacios, J.

Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.

Moreno-Bueno, G , Sánchez-Estévez, C, Cassia, R, Rodríguez-Perales, S, Díaz-Uriarte, R , Domínguez, O, Hardisson, D, Andujar, M, Prat, J, Matias-Guiu, X, Cigudosa, JC, Palacios, J.

Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.

Sarrió, D , Moreno-Bueno, G , Hardisson, D, Sánchez-Estévez, C, Guo, M, Herman, JG, Gamallo, C , Esteller, M, Palacios, J.

Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.

Moreno-Bueno, G , Hardisson, D, Sarrió, D , Sánchez, C, Cassia, R, Prat, J, Herman, JG, Esteller, M, Matías-Guiu, X, Palacios, J.

Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors.

Gras, E, Catasus, L, Argüelles, R, Moreno-Bueno, G , Palacios, J, Gamallo, C , Matias-Guiu, X, Prat, J.

beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.

Moreno-Bueno, G , Gamallo, C , Pérez-Gallego, L, Contreras, F, Palacios, J.

Correlation of p53 oncoprotein expression with chemotherapy response in small cell lung carcinomas.

Rodríguez-Salas, N, Palacios, J, Moreno, G , de Castro, J, González-Barón, M, Gamallo, C .

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.

Moreno-Bueno, G , Gamallo, C , Pérez-Gallego, L, de Mora, JC, Suárez, A, Palacios, J.

Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability.

Palacios, J, Catasús, L, Moreno-Bueno, G , Matias-Guiu, X, Prat, J, Gamallo, C .

Beta-catenin expression pattern in small cell lung cancer: correlation with clinical and evolutive features.

Rodríguez-Salas, N, Palacios, J, de Castro, J, Moreno, G , González-Barón, M, Gamallo, C .

beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome.

de Castro, J, Gamallo, C , Palacios, J, Moreno-Bueno, G , Rodríguez, N, Feliu, J, González-Barón, M.

beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome.

Gamallo, C , Palacios, J, Moreno, G , Calvo de Mora, J, Suárez, A, Armas, A.

C/ Arturo Duperier 4 | 28029 Madrid (España) | Teléfono +(34) 91 585 4400 | Código DIR3: E02764003